Pulmonx Corp CCO sells 8,023 shares for tax withholding

Pulmonx Corp’s Chief Commercial Officer Geoffrey Beran Rose reported selling a total of 8,023 shares of common stock on June 1, 2026 in four transactions at $1.5400 per share.

Rhea-AI Filing Summary

Pulmonx Corp’s Chief Commercial Officer Geoffrey Beran Rose reported selling a total of 8,023 shares of common stock on June 1, 2026 in four transactions at $1.5400 per share. Footnotes state these sales were made to cover tax withholding obligations related to vesting Restricted Stock Units granted from 2023 through 2026. After these transactions, he directly holds 457,711 Pulmonx common shares.

Insider Trade Summary

Net Seller: 8,023 shares

Net Sell 4 txns

Insider Rose Geoffrey Beran

Role CHIEF COMMERCIAL OFFICER

Sold 8,023 shs ($12K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,778	$1.54	$3K
Sale	Common Stock	1,557	$1.54	$2K
Sale	Common Stock	2,434	$1.54	$4K
Sale	Common Stock	2,254	$1.54	$3K

Holdings After Transaction: Common Stock — 457,711 shares (Direct)

Footnotes (4)

1. F1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
2. F2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
3. F3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
4. F4. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.

Key Figures

Shares sold: 8,023 shares Sale price: $1.5400 per share Post-transaction holdings: 457,711 shares +1 more

4 metrics

Shares sold 8,023 shares Total common shares sold on June 1, 2026

Sale price $1.5400 per share Price for each Pulmonx common share sold

Post-transaction holdings 457,711 shares Direct Pulmonx common stock holdings after reported sales

Number of sale transactions 4 Separate non-derivative common stock sales on June 1, 2026

Key Terms

Restricted Stock Units, tax withholding obligations, Common Stock, RSUs

4 terms

Restricted Stock Units financial

"in connection with the vesting of the Restricted Stock Units (the "RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"These shares were sold by the reporting person to cover tax withholding obligations"

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

RSUs financial

"in connection with the vesting of the RSUs granted on March 1, 2023"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider stock activity did Pulmonx Corp (LUNG) report for Geoffrey Beran Rose?

Geoffrey Beran Rose reported selling 8,023 Pulmonx common shares on June 1, 2026 in four transactions at $1.5400 per share. The sales were disclosed as covering tax withholding obligations tied to the vesting of multiple Restricted Stock Unit grants.

How many Pulmonx Corp (LUNG) shares did Geoffrey Beran Rose sell and at what price?

He sold a total of 8,023 Pulmonx common shares at $1.5400 per share. The sales were reported as non-derivative, open-market or private transactions, all executed on June 1, 2026, and linked in footnotes to RSU vesting-related tax withholding.

Why were Geoffrey Beran Rose’s Pulmonx (LUNG) share sales conducted?

The transactions’ footnotes state that the shares were sold to cover tax withholding obligations arising from the vesting of Restricted Stock Units. These RSUs were originally granted on March 1, 2023, March 1, 2024, March 3, 2025, and March 2, 2026.

What Pulmonx Corp (LUNG) holdings does Geoffrey Beran Rose have after the sales?

After the reported transactions, Geoffrey Beran Rose directly holds 457,711 Pulmonx common shares. This post-transaction balance reflects his remaining ownership position following the 8,023-share sale used to satisfy RSU-related tax withholding obligations.

Were Geoffrey Beran Rose’s Pulmonx (LUNG) share sales under a Rule 10b5-1 plan?

The transactions were not affirmed as being under a Rule 10b5-1 trading plan, as the plan checkbox was marked false. The filing instead explains via footnotes that the sales were made to cover tax withholding from vesting Restricted Stock Units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rose Geoffrey Beran

(Last) (First) (Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF COMMERCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)		1,778	D	$1.54	463,956	D
Common Stock	06/01/2026		S(2)		1,557	D	$1.54	462,399	D
Common Stock	06/01/2026		S(3)		2,434	D	$1.54	459,965	D
Common Stock	06/01/2026		S(4)		2,254	D	$1.54	457,711	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.

2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.

3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.

4. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.

	/s/ David Aaron Lehman, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)